Found: 6
Select item for more details and to access through your institution.
Comparison of the effectiveness, safety, and costs of anti‐Parkinson drugs: A multiple‐center retrospective study.
- Published in:
- CNS Neuroscience & Therapeutics, 2024, v. 30, n. 4, p. 1, doi. 10.1111/cns.14531
- By:
- Publication type:
- Article
Therapeutic drug monitoring guidelines in oncology: what do we know and how to move forward? Insights from a systematic review.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241250130
- By:
- Publication type:
- Article
Medication adherence and costs of medical care among patients with Parkinson's disease: an observational study using electronic medical records.
- Published in:
- BMC Public Health, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12889-024-18431-y
- By:
- Publication type:
- Article
The Role of Genetic Polymorphisms in High-Dose Methotrexate Toxicity and Response in Hematological Malignancies: A Systematic Review and Meta-Analysis.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.757464
- By:
- Publication type:
- Article
Toward Genetic Testing of Rivaroxaban? Insights from a Systematic Review on the Role of Genetic Polymorphism in Rivaroxaban Therapy.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 3, p. 279, doi. 10.1007/s40262-024-01358-3
- By:
- Publication type:
- Article
Comparative efficacy and safety between amisulpride and olanzapine in schizophrenia treatment and a cost analysis in China: a systematic review, meta-analysis, and cost-minimization analysis.
- Published in:
- BMC Psychiatry, 2018, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12888-018-1867-8
- By:
- Publication type:
- Article